Elixxer Ltd.
ELIXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $7 | $7,168,165 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $12 | $10 | $7 | $4 |
| Enterprise Value | $12 | $10 | $14 | $7,168,168 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 112.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 100% | 96.3% |
| EBITDA | $0 | $0 | -$12 | -$1 |
| % Margin | – | – | -17,385.3% | -3,905.8% |
| Net Income | -$0 | -$0 | -$14 | -$2 |
| % Margin | – | – | -21,169.1% | -6,827.6% |
| EPS Diluted | -0 | -0 | -1.27 | -0.245 |
| % Growth | 0% | 100% | -419.2% | – |
| Operating Cash Flow | $0 | -$2 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$2 | -$2 | -$2 |